Skip to main content
Clinical Trials/NCT03410069
NCT03410069
Completed
N/A

Monitoring Tissue Perfusion in Critically Ill or High-risk Surgical Patients: a Pilot Clinical Study To Evaluate the aPplicability and the Safety of Urethral Perfusion Measurement With the IKORUS System

Advanced Perfusion Diagnostics4 sites in 1 country30 target enrollmentAugust 3, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
High-risk Surgical Patients
Sponsor
Advanced Perfusion Diagnostics
Enrollment
30
Locations
4
Primary Endpoint
Incidence of complications
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Circulatory shock is defined as an imbalance between oxygen supply and/or impaired oxygen use to maintain organ function. With growing evidence of lack of correlation between macro- and micro-circulation, use of "Whole Body" markers such as blood pressure (BP) or Lactates are often insufficient to assess the severity of the oxygen debt and/or tissue hypoperfusion. Thus, an approach incorporating tissue-perfusion based endpoints would represent a significant step up to guide optimal resuscitation of critically-ill patients and to reduce complications in high-risk surgery.

Current monitoring techniques, that complement systemic hemodynamics by focusing on regional perfusion, still lack the required user-friendliness and/or clinical relevance to be routinely used at bedside. Therefore, assessment of the adequacy of tissue perfusion and oxygenation is suboptimal, and implementation of the above-mentioned approaches of resuscitation is still a challenge.

Urethral perfusion is likely to be early and significantly impaired during low-flow states and thus represents a good "candidate" as a surrogate site to assess the perfusion of visceral organs. Besides, urethral mucosa can be investigated in a less invasive and simpler manner than "deeper" organs. Nowadays, no practical methods or devices are available to monitor perfusion in the pelvic area. Thus, recent development of a new monitoring device of urethral perfusion could fill this need and enable enhanced management of patients in Intensive Care Units (ICU) and Operating Rooms (OR).

The device consists of a modified Foley catheter equipped with a photoplethysmographic sensor: the IKORUS UP probe.

The probe will be used by intensivists or anesthesiologists on high-risk surgical patients, i.e. patients with comorbidities undergoing major vascular, thoracic and/or abdominal surgery.

Registry
clinicaltrials.gov
Start Date
August 3, 2018
End Date
May 7, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Advanced Perfusion Diagnostics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Incidence of complications

Time Frame: 28 days

Complications rate: Injury during insertion; Bleeding; Infection; Pain; Discomfort.

Secondary Outcomes

  • Signal acquisition(28 days)
  • Evolution of SpO2(28 days)
  • Evolution of SVO2(28 days)
  • Evolution of central venous pressure(28 days)
  • Evolution of mean arterial pressure(28 days)
  • Evolution of catecholamine infusions levels(28 days)
  • Effect of the position of the sensor(28 days)
  • Evolution of lactates dosages(28 days)
  • Evolution of cardiac outputs(28 days)
  • Applicability of the procedure(28 days)
  • Quality of the signal(28 days)
  • Rate of resuscitation events(28 days)

Study Sites (4)

Loading locations...

Similar Trials